Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Nutr Food Res ; 64(20): e2000354, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32918392

RESUMEN

SCOPE: To investigate the effects of squalene, the main hydrocarbon present in extra virgin olive oil, on liver transcriptome in different animal models and to test the influence of sex on this action and its relationship with hepatic lipids. METHODS AND RESULTS: To this purpose, male C57BL/6J Apoe-deficient mice are fed a purified Western diet with or without squalene during 11 weeks and hepatic squalene content is assessed, so are hepatic lipids and lipid droplets. Hepatic transcriptomic changes are studied and confirmed by RT-qPCR. Dietary characteristics and influence of squalene doses are tested in Apoe-deficient on purified chow diets with or without squalene. These diets are also given to Apoa1 and wild-type mice on C57BL/6J background and to C57BL/6J xOla129 Apoe-deficient mice. Squalene supplementation increases its hepatic content without differences among sexes and hormonal status. The Cyp2b10 and Cyp2c55 gene expressions are significantly up-regulated by the squalene intake in all models, with independence of sex, sexual hormones, dietary fat content, genetic background and dose, and in Apoe-deficient mice consuming extra-virgin olive oil. CONCLUSION: Hepatic squalene increases the expression of these cytochromes and their changes in virgin olive oil diets may be due to their squalene content.


Asunto(s)
Hidrocarburo de Aril Hidroxilasas/genética , Familia 2 del Citocromo P450/genética , Hígado/efectos de los fármacos , Escualeno/farmacología , Esteroide Hidroxilasas/genética , Animales , Apolipoproteína A-I/genética , Apolipoproteínas E/genética , Castración , Citocromo P-450 CYP2B6/genética , Dieta Occidental , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Células Hep G2 , Humanos , Lípidos/sangre , Hígado/fisiología , Masculino , Ratones Endogámicos C57BL , Escualeno/administración & dosificación
2.
Int J Mol Sci ; 18(2)2017 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-28212288

RESUMEN

Low levels of paraoxonase 1 (PON1) have been associated with the development of several pathological conditions, whereas high levels have been shown to be anti-atherosclerotic in mouse models. These findings suggest that PON1 could be a good surrogate biomarker. The other members of the family, namely PON2 and PON3, the role of which has been much less studied, deserve more attention. This paper provides a systematic review of current evidence concerning dietary supplements in that regard. Preliminary studies indicate that the response to dietary supplements may have a nutrigenetic aspect that will need to be considered in large population studies or in clinical trials. A wide range of plant preparations have been found to have a positive action, with pomegranate and some of its components being the best characterized and Aronia melanocarpa one of the most active. Flavonoids are found in the composition of all active extracts, with catechins and genistein being the most promising agents for increasing PON1 activity. However, some caveats regarding the dose, length of treatment, bioavailability, and stability of these compounds in formulations still need to be addressed. Once these issues have been resolved, these compounds could be included as nutraceuticals and functional foods capable of increasing PON1 activity, thereby helping with the long-term prevention of atherosclerosis and other chronic ailments.


Asunto(s)
Arildialquilfosfatasa/metabolismo , Suplementos Dietéticos , Aminoácidos , Animales , Arildialquilfosfatasa/sangre , Arildialquilfosfatasa/química , Dieta , Activación Enzimática , Jugos de Frutas y Vegetales , Humanos , Isoenzimas , Lípidos , Lythraceae/química , Nutrigenómica , Fenoles/química , Fitoquímicos/química , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Proteínas , Vitaminas/química
3.
PLoS One ; 9(8): e104224, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25117703

RESUMEN

BACKGROUND AND PURPOSE: Squalene, the main hydrocarbon in the unsaponifiable fraction of virgin olive oil, is involved in cholesterol synthesis and it has been reported to own antiatherosclerotic and antiesteatosic effects. However, the squalene's role on lipid plasma parameters and the influence of genotype on this effect need to be addressed. EXPERIMENTAL APPROACHES: Three male mouse models (wild-type, Apoa1- and Apoe- deficient) were fed chow semisynthetic diets enriched in squalene to provide a dose of 1 g/kg during 11 weeks. After this period, their plasma parameters and lipoprotein profiles were analyzed. KEY RESULTS: Squalene administration at a dose of 1 g/kg showed decreased reactive oxygen species in lipoprotein fractions independently of the animal background and caused an specific increase in high density lipoprotein (HDL)-cholesterol levels, accompanied by an increase in phosphatidylcholine and paraoxonase 1 and no changes in apolipoproteins A1 and A4 in wild-type mice. In these mice, the cholesterol increase was due to its esterified form and associated with an increased hepatic expression of Lcat. These effects were not observed in absence of apolipoprotein A1. The increases in HDL- paraoxonase 1 were translated into decreased plasma malondialdehyde levels depending on the presence of Apolipoprotein A1. CONCLUSIONS AND IMPLICATIONS: Dietary squalene promotes changes in HDL- cholesterol and paraoxonase 1 and decreases reactive oxygen species in lipoproteins and plasma malondialdehyde levels, providing new benefits of its intake that might contribute to explain the properties of virgin olive oil, although the phenotype related to apolipoproteins A1 and E may be particularly relevant.


Asunto(s)
Arildialquilfosfatasa/sangre , HDL-Colesterol/sangre , Suplementos Dietéticos , Estrés Oxidativo , Escualeno/administración & dosificación , Animales , Glucemia/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Lípidos/sangre , Lipoproteínas/sangre , Lipoproteínas/metabolismo , Hígado/anatomía & histología , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Ratones Noqueados , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo
4.
J Nutr Biochem ; 24(12): 2100-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24231102

RESUMEN

Oleanolic acid is a triterpene widely distributed throughout the plant kingdom and present in virgin olive oil at a concentration of 57 mg/kg. To test the hypotheses that its long-term administration could modify hepatic gene expression in several animal models and that this could be influenced by the presence of APOA1-containing high-density lipoproteins (HDLs), diets including 0.01% oleanolic acid were provided to Apoe- and Apoa1-deficient mice and F344 rats. Hepatic transcriptome was analyzed in Apoe-deficient mice fed long-term semipurified Western diets differing in the oleanolic acid content. Gene expression changes, confirmed by reverse transcriptase quantitative polymerase chain reaction, were sought for their implication in hepatic steatosis. To establish the effect of oleanolic acid independently of diet and animal model, male rats were fed chow diet with or without oleanolic acid, and to test the influence of HDL, Apoa1-deficient mice consuming the latter diet were used. In Apoe-deficient mice, oleanolic acid intake increased hepatic area occupied by lipid droplets with no change in oxidative stress. Bmal1 and the other core component of the circadian clock, Clock, together with Elovl3, Tubb2a and Cldn1 expressions, were significantly increased, while Amy2a5, Usp2, Per3 and Thrsp were significantly decreased in mice receiving the compound. Bmal1 and Cldn1 expressions were positively associated with lipid droplets. Increased Clock and Bmal1 expressions were also observed in rats, but not in Apoa1-deficient mice. The core liver clock components Clock-Bmal1 are a target of oleanolic acid in two animal models independently of the diets provided, and this compound requires APOA1-HDL for its hepatic action.


Asunto(s)
Factores de Transcripción ARNTL/metabolismo , Apolipoproteína A-I/genética , Proteínas CLOCK/metabolismo , Relojes Circadianos/genética , Hígado/efectos de los fármacos , Ácido Oleanólico/farmacología , Factores de Transcripción ARNTL/genética , Acetiltransferasas/genética , Acetiltransferasas/metabolismo , Animales , Apolipoproteína A-I/deficiencia , Apolipoproteína A-I/metabolismo , Apolipoproteínas E/deficiencia , Apolipoproteínas E/genética , Apolipoproteínas E/metabolismo , Proteínas CLOCK/genética , HDL-Colesterol/sangre , Claudina-1/genética , Claudina-1/metabolismo , Elongasas de Ácidos Grasos , Expresión Génica , Células Hep G2 , Humanos , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Modelos Animales , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Aceite de Oliva , Estrés Oxidativo/efectos de los fármacos , Proteínas Circadianas Period/genética , Proteínas Circadianas Period/metabolismo , Aceites de Plantas/química , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas F344 , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Ubiquitina Tiolesterasa , Proteasas Ubiquitina-Específicas/genética , Proteasas Ubiquitina-Específicas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA